[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"cervical-mucus\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:cervical-mucus":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":5},"100601496","phase-4-insights-in-endocervical-mucus-secretion-100601496",false,"NCT07111247","Insights in Endocervical Mucus Secretion","Inclusion Criteria:\n\n* Normal menstrual cycles of 25-35 days in length for at least the previous 3 cycles\n* BMI \\>18 and \\\u003C35\n* Serum p4 \\>= 3 ng\u002Fml on single sample collected between days 18-25 of self-reported menstrual cycle\n* Flexible schedule allowing blood draws on less than 48 hour notice\n* In good general health\n* Commit to using non-hormonal contraceptive methods without spermicide during study period except those prescribed in the experimental protocol\n* No objections to taking study drugs\n* No objections to refraining from intercourse the night before any sampling and willing to use condoms during vaginal intercourse\n\nExclusion Criteria:\n\n* Oral contraceptive use or other hormone supplement within the preceding 2 months\n* Current cervical infection\n* Evidence of abnormal cervical cytology\n* Use of any IUD for contraception\n* Long-acting hormonal contraceptive use in the past 12 months (e.g., Depo-Provera)\n* Contraindications to study drugs\n* Current or past pregnancy within the previous 6 months or currently trying to conceive\n* Desiring to conceive in the next 8 months\n* Breastfeeding in the past 2 months\n* Diagnosed diabetes or metabolic syndrome\n* Diagnosed Polycystic Ovary Syndrome\n* History of, or self-reported, substance abuse\n* Smoker\n* Previous infertility treatment excluding male factor issues\n* Use of an investigational drug within the past 2 months\n* History of excisional or ablative treatment procedure on cervix (i.e., LEEP, Cryotherapy, Cold Knife Cone)\n* Current treatment for a vaginal infection such as bacterial vaginosis\n* History of venous thromboembolism (VTE) or inherited thrombophilias",true,"FEMALE","21 Years","40 Years",{"count":20,"type":21},15,"ESTIMATED","INTERVENTIONAL",[24],"PHASE4","Single arm interventional study looking at biological outcomes at 4 time points throughout the cycle before and after taking an oral gonadotropin-releasing hormone antagonist (gnRH). Samples of whole blood, endocervical mucus, endocervical biopsy, and vaginal swab will be collected.",[27],"Cervical Mucus","RECRUITING","2026-01-06",{"date":31,"type":32},"2026-01-08","ACTUAL",{"date":34,"type":32},"2026-01-02",{"date":36,"type":21},"2027-08",{"name":38,"class":39},"Oregon Health and Science University","OTHER"]